Literature DB >> 9019031

Decreased opioid doses used on a palliative care unit.

R L Fainsinger1, K Louie, M Belzile, E Bruera, J Hanson.   

Abstract

We have previously published data on our use of opioids in the last week of life. A change in our pattern of opioid use, i.e. switching opioids more frequently and using high-dose methadone suppositories, appears to have resulted in a decrease in the number of patients requiring high-dose opioids. A retrospective chart review of 100 consecutive patients treated on our palliative care unit during 1992 was completed and compared to the original data from 1990. Results confirmed a decrease in the range of opioids used, as well as a statistically significant decrease in the daily opioid dose in the last week of life. We believe that this difference is most likely due to the use of methadone in patients showing either a poor response to other opioids or a rapid development to tolerance, as well as switching opioids more frequently to take advantage of incomplete cross-tolerance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9019031

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  4 in total

Review 1.  Alternative opioids to morphine in palliative care: a review of current practice and evidence.

Authors:  M Barnett
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

2.  Use of patient-controlled analgesia for pain control in dying children.

Authors:  Christine Schiessl; Chara Gravou; Boris Zernikow; Reinhard Sittl; Norbert Griessinger
Journal:  Support Care Cancer       Date:  2008-02-15       Impact factor: 3.603

3.  Intravenous morphine consumption in outpatients with cancer during their last week of life--an analysis based on patient-controlled analgesia data.

Authors:  Christine Schiessl; Reinhard Sittl; Norbert Griessinger; Norbert Lutter; Juergen Schuettler
Journal:  Support Care Cancer       Date:  2007-10-25       Impact factor: 3.603

4.  The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.

Authors:  Suresh Reddy; David Hui; Badi El Osta; Maxine de la Cruz; Paul Walker; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.